148 related articles for article (PubMed ID: 10225558)
1. The effect of heterogeneity in tumor cell kinetics on radiation dose-response. An exploratory investigation of a plateau effect.
Suwinski R; Taylor JM; Withers HR
Radiother Oncol; 1999 Jan; 50(1):57-66. PubMed ID: 10225558
[TBL] [Abstract][Full Text] [Related]
2. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
3. Modeling the effect of intratumoral heterogeneity of radiosensitivity on tumor response over the course of fractionated radiation therapy.
Alfonso JCL; Berk L
Radiat Oncol; 2019 May; 14(1):88. PubMed ID: 31146751
[TBL] [Abstract][Full Text] [Related]
4. [Radiation sensitivity for delayed reproductive death (DRD) following single or split-dose irradiation].
Hagemann G; Lipfert CH; Wüppen G
Strahlenther Onkol; 2001 Oct; 177(10):538-46. PubMed ID: 11680019
[TBL] [Abstract][Full Text] [Related]
5. The influence of repopulation kinetics on isoeffect doses for permanent implants.
Kneschaurek P
Strahlenther Onkol; 1994 Oct; 170(10):602-7. PubMed ID: 7974172
[TBL] [Abstract][Full Text] [Related]
6. The effect of stochastic fluctuation in radiation dose-rate on cell survival following fractionated radiation therapy.
Paul S; Roy PK
Phys Med Biol; 2012 Mar; 57(6):1561-73. PubMed ID: 22391148
[TBL] [Abstract][Full Text] [Related]
7. Should single or distributed parameters be used to explain the steepness of tumour control probability curves?
Daşu A; Toma-Daşu I; Fowler JF
Phys Med Biol; 2003 Feb; 48(3):387-97. PubMed ID: 12608614
[TBL] [Abstract][Full Text] [Related]
8. [Quantitative evaluation of tumor radiation reactions by their radiobiological parameters].
Lisin VA; Musabaeva LI
Med Radiol (Mosk); 1983 Dec; 28(12):30-4. PubMed ID: 6645839
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of heterogeneity of tumor response to radiation therapy.
Suit H; Skates S; Taghian A; Okunieff P; Efird JT
Radiother Oncol; 1992 Dec; 25(4):251-60. PubMed ID: 1480770
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of molecular biotherapies with radical radiotherapy: modeling of combined modality treatment schedules.
Jones B; Dale RG
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1025-34. PubMed ID: 10571212
[TBL] [Abstract][Full Text] [Related]
11. Are hypoxic cells critical for the outcome of fractionated radiotherapy in a slow-growing mouse tumor?
Urano M; Nishimura Y; Kuroda M; Reynolds R
Radiother Oncol; 1998 Aug; 48(2):221-8. PubMed ID: 9783896
[TBL] [Abstract][Full Text] [Related]
12. Selective boosting of tumor subvolumes.
Tomé WA; Fowler JF
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):593-9. PubMed ID: 10974480
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
Stuschke M; Budach V; Stüben G; Streffer C; Sack H
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
[TBL] [Abstract][Full Text] [Related]
14. Fractionated radiation therapy after Strandqvist.
Fowler JF
Acta Radiol Oncol; 1984; 23(4):209-16. PubMed ID: 6093436
[TBL] [Abstract][Full Text] [Related]
15. The role of radiation in the treatment of cancer:radiobiologic and cell kinetic concepts.
Archambeau JO; Shymko RM
Curr Probl Cancer; 1984 Jul; 8(13):1-56. PubMed ID: 6434233
[No Abstract] [Full Text] [Related]
16. Dose-response relationship for radiation therapy of subclinical disease.
Withers HR; Peters LJ; Taylor JM
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):353-9. PubMed ID: 7836089
[TBL] [Abstract][Full Text] [Related]
17. Cell kinetics and radiation biology.
Denekamp J
Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Feb; 49(2):357-80. PubMed ID: 3510997
[TBL] [Abstract][Full Text] [Related]
18. Mathematical Modeling of the Effects of Tumor Heterogeneity on the Efficiency of Radiation Treatment Schedule.
Forouzannia F; Enderling H; Kohandel M
Bull Math Biol; 2018 Feb; 80(2):283-293. PubMed ID: 29218592
[TBL] [Abstract][Full Text] [Related]
19. The decreased influence of overall treatment time on the response of human breast tumor xenografts following prolongation of the potential doubling time (Tpot).
Sarkaria JN; Fowler JF; Lindstrom MJ; Jordan VC; Mulcahy RT
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):833-40. PubMed ID: 7860396
[TBL] [Abstract][Full Text] [Related]
20. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
